Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014

3 Visualizzazioni
administrator
administrator
07/30/23

Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.

Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com

  • Categoria

Mostra di più

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo